Entero Therapeutics (ENTO)
NASDAQ:ENTO
US Market
Holding ENTO?
Track your performance easily

Entero Therapeutics (ENTO) Financial Statements

1,229 Followers

Entero Therapeutics Financial Overview

Entero Therapeutics's market cap is currently ―. The company's EPS TTM is $-49.226; its P/E ratio is >-0.01; Entero Therapeutics is scheduled to report earnings on August 13, 2019, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue----$ -595.00K
Gross Profit----$ -595.00K
EBIT-$ -3.43M$ -4.18M$ -4.06M$ -561.74K
EBITDA-$ -3.43M$ -4.18M$ -4.05M$ -554.42K
Net Income Common Stockholders$ -20.28M$ -3.48M$ -4.28M$ -4.16M$ -1.63M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 3.71M$ 3.29M$ 1.24M$ 2.06M$ 1.36M
Total Assets$ 6.88M$ 5.93M$ 4.33M$ 5.50M$ 5.44M
Total Debt$ 826.84K$ 231.29K$ 401.70K$ 644.85K$ 883.71K
Net Debt$ -2.88M$ -3.06M$ -834.35K$ -1.42M$ -479.20K
Total Liabilities$ 3.28M$ 2.65M$ 3.45M$ 2.82M$ 2.70M
Stockholders Equity$ 3.60M$ 3.28M$ 881.96K$ 2.71M$ 2.74M
Cash Flow-
Free Cash Flow-$ -3.33M$ -2.76M$ -2.85M$ -5.59M
Operating Cash Flow$ -3.44M$ -3.33M$ -2.76M$ -2.85M$ -5.59M
Investing Cash Flow$ -500.00K----
Financing Cash Flow$ 4.36M$ 5.39M$ 1.93M$ 3.55M$ 5.52M
Currency in USD

Entero Therapeutics Earnings and Revenue History

Entero Therapeutics Debt to Assets

Entero Therapeutics Cash Flow

Entero Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis